News Legal Alert life sciences News Publications
Thursday May 16th, 2024
Sorry, this entry is only available in Polish.
Sorry, this entry is only available in Polish.
We are pleased to announce that the „International Advertising Law: A Practical Global Guide – Second Edition” has been published by…
According to the EU Directive, Member States shall ensure that medicinal products which are Over-The-Counter Drug (OTC) are offered for…
RESTRICTIONS ON TRADE Adding more products to the anti-export list (the requirement to report export to the Chief Pharmaceutical Inspectorate (GIF) 30 days…
We are pleased to inform that veterinary clinic “Molicki” located in Dąbrowa Górnicza has joined AniCura, a family of leading…
EU regulations on medical devices (MDR[1]) and in vitro diagnostic medical devices (IVDR[2]) have been applied for several years now…
“Sugars occurring naturally in beverages are not subject to the fee on foodstuffs and, as a result, their quantity (content)…
In July last year, we reported that due to ongoing discussions, the possibility of limiting the sale of energy drinks…
During a January meeting of the Parliamentary Committee on Economy and Development,[1] the President of the Office of Competition and…
“SK&S’ transaction team has advised AniCura AB in the acquisition process of veterinary clinic “Gliwcka Przychodnia Weterynaryjna”. One of the…
The hemp market includes food products, cosmetic products, but also pharmaceutical raw materials or products for animals. What should an…
The hemp industry is not only one of the fastest growing in Poland, but also worldwide. New products made with…
SK&S’ transaction team advised Velocity Clinical Research Inc.—the leading multi-specialty clinical sites business, in the acquisition of KO-MED Clinical Centers—one…
The introduction of Regulation (EU) 2017/745 on Medical Devices (“MDR”) gave rise to a number of questions regarding products which…
We are pleased to inform that veterinary clinic “Wróblewscy” located in Dąbrowa Górnicza has joined AniCura, a family of leading…
SK&S’ transaction team advised Velocity Clinical Research Inc.—the leading multi-specialty clinical sites business, in the acquisition of its first site…